Business Description
This fund puts at least 90% of its money into the same stocks that make up its benchmark index, which tracks 30 American pharmaceutical companies. These businesses focus primarily on creating, making, and selling medicines and drugs of all kinds. Because the fund concentrates on a small group of companies within a single industry, it carries more risk than a broadly spread investment.
